Arrowhead Pharmaceuticals Inc. sell StockNews.com
Start price
22.11.23
/
50%
€26.71
Target price
22.11.24
-
Performance (%)
-32.59%
End price
23.11.24
€18.01
Summary
This prediction ended on 23.11.24 with a price of €18.01. StockNews_com correctly predicted massive losses of -32.59% for Arrowhead Pharmaceuticals Inc.. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Arrowhead Pharmaceuticals Inc. | 13.154% | 13.154% | 182.136% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by StockNews_com for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for ARWR provided by MarketBeat
In the thread Trading Arrowhead Pharmaceuticals Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.03
28.11.24
28.11.24
-
28.11.25
28.11.25
79.22%
29.11.25
29.11.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.10
30.09.23
30.09.23
-
30.09.24
30.09.24
-30.14%
01.10.24
01.10.24